Statistics notes: Treatment allocation in controlled trials: why randomise?
- 1 May 1999
- Vol. 318 (7192) , 1209
- https://doi.org/10.1136/bmj.318.7192.1209
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996
- Improving the quality of reporting of randomized controlled trials. The CONSORT statementJAMA, 1996
- Why we need observational studies to evaluate the effectiveness of health careBMJ, 1996
- Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyPublished by Elsevier ,1991
- Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.1991
- Randomisation.BMJ, 1991
- Randomized versus historical controls for clinical trialsThe American Journal of Medicine, 1982
- POSSIBLE PREVENTION OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATIONThe Lancet, 1980
- STREPTOMYCIN treatment of pulmonary tuberculosis.1948
- Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council InvestigationBMJ, 1948